295 articles
Jeremy Abramson, Director of the Lymphoma Program and the Jon and Jo Ann Hagler Chair in Lymphoma at the Massachusetts General Hospital Cancer Center an...
Returning guest, Sylvie Beljanski, Founder and Executive Vice President of the Beljanski Foundation and a renowned expert in the field of natural approa...
Nicholas Robert, CMO of Ontada, discusses new research that examines potential factors that may impact care and outcomes for affected communities with a...
Mark Stadler, CEO of AccessHope discusses cancer care and why access to the best cancer facilities is out of reach for the majority of Americans, partic...
Ahsan Arozullah, MD, MPH, Senior Vice President, Head of Oncology Development at Astellas discusses the company's presence at the 2023 American Soci...
Joe Ferra, Interim CEO and CFO of Elevation Oncology discusses the company's development of an antibody-drug conjugate (ADC) that targets Claudin18.2, a...
Susana Banerjee, Consultant Medical Oncologist and Research Lead for the Gynecology unit at Royal Marsden NHS and lead investigator discusses results fr...
Dirk Huebner, MD, Chief Medical Officer at Aptevo Therapeutics, a biotech company, discusses the company's focus on bringing novel immuno-oncology thera...
Douglas Rex, MD, Distinguished Professor Emeritus at Indiana University School of Medicine and a full-time clinical gastroenterologist at Indiana Univer...
Meredith Manning, President of the Americas at PharmaEssentia, a global biotech, discusses the company’s work utilizing the power of interferons, a na...